Novartis Sees Sales Growth Through 2031来源:WSJ发布于 2026-11-19The drugmaker expects annual sales growth of 5% from 2026 to 2031, from a previous forecast of 5% to 6% over the 2025-30 period.相关标的:NVS继续访问返回新闻本文内容来自外部来源,点击「继续访问」将跳转到原始发布站点。